Abstract:Background: Circular RNAs (circRNAs), a novel type of ncRNAs, are covalently linked to make up circular configuration via a loop structure. Accumulating evidence indicate that circRNAs are potential biomarkers and key regulators in the development and progression of tumors. However, the precise role of circRNAs in renal cell carcinoma (RCC) remains unknown.Methods: Though circRNA high-throughput sequencing from RCC cell lines, we determined circRNA TLK1 (circTLK1 ) as a novel candidate circRNA derived from TLK1 gene. Quantitative real-time PCR (qRT-PCR) was performed to detect the expression levels of mRNAs, circRNAs and miRNAs in RCC tissues and cells. Loss-of function experiments were executed to detect the biological roles of circTLK1 on the phenotypes of RCC cells in vitro and in vivo. RNA-FISH, RNA-pull down, dual-luciferase reporter, western blot and immunohistochemistry assay were used to investigate the molecular mechanisms underlying the functions of circTLK1.Findings: CircTLK1 is overexpressed in RCC and positively corelated with distant metastasis and unfavorable prognosis. Silence of circTLK1 significantly inhibits the proliferation, migration and invasion of RCC cells in vitro and in vivo. Mechanistically, circTLK1 is mainly distributed in the cytoplasm and positively regulates CBX4 expression by sponging miR-136-5p. In addition, forced expression of CBX4 reverses the phenotypes inhibition of RCC cells induced by circTLK1 suppression. Moreover, CBX4 expression is positively corelated with VEGF expression in renal cancer tissues. Knockdown of CBX4 significantly inhibited VEGF expression in RCC cells.Interpretation: Collectively, our findings demonstrate that circTLK1 plays a critical role in RCC progression by sponging miR-136-5p to increase CBX4 expression. CircTLK1 may act as a diagnostic biomarker and therapeutic target for RCC.Funding Statement: This study was supported by grants from Guangdong Key Laboratories (2017B030314074) and the Shenzhen Project of Science and Technology (JCYJ20170413100245260).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: This study was approved by the ethical committee of Perking University Shenzhen Hospital. All patients agreed that their samples could be applied to the experimental studies and paper presentations.In vivo assay was approved by the animal management committee of Perking University Shenzhen Hospital, and all experimental procedures and animal care were in line with the institutional ethics guidelines for animal experiments.

The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis

circFOXO3 Induced by KLF16 Modulates Clear Cell Renal Cell Carcinoma Growth and Natural Killer Cell Cytotoxic Activity through Sponging miR-29a-3p and miR-122-5p

MiR-532-5p Suppresses Renal Cancer Cell Proliferation by Disrupting the ETS1-mediated Positive Feedback Loop with the KRAS-NAP1L1/P-ERK Axis

Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway

MiRNA-206 Inhibits Proliferation of Renal Clear Cell Carcinoma by Targeting ZEB2.

MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways

MicroRNA‑9‑5p Downregulates Klf4 and Influences the Progression of Hepatocellular Carcinoma Via the AKT Signaling Pathway.

MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.

Long Noncoding RNA KIF9-AS1 Regulates Transforming Growth Factor-β and Autophagy Signaling to Enhance Renal Cell Carcinoma Chemoresistance Via Microrna-497-5p.

CircTLK1 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Sponging Mir-136-5p and Regulating CBX4 Expression

MiR-543 promotes cell proliferation and metastasis of renal cell carcinoma by targeting Dickkopf 1 through the Wnt/β-catenin signaling pathway.

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

MicroRNA-183 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Targeting Dickkopf-related Protein 3

Microrna-191-5p Exerts A Tumor Suppressive Role In Renal Cell Carcinoma

Dysregulation of KCNQ1OT1 Promotes Cholangiocarcinoma Progression Via Mir-140-5p/sox4 Axis.

MiR-6838-5p Facilitates the Proliferation and Invasion of Renal Cell Carcinoma Cells Through Inhibiting the DMTF1/ARF-p53 Axis

MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients.

Long Non‑coding RNA PLK1S1 Was Associated with Renal Cell Carcinoma Progression by Interacting with Microrna‑653 and Altering C‑X‑C Chemokine Receptor 5 Expression.

MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration by Targeting the Mitogen-Activated Protein Kinase Kinase Kinase 8 Oncogene in Renal Cell Carcinoma